Quality of life after adjuvant chemotherapy for breast cancer
Purpose.To evaluate the quality of life of breast cancer patients previously treated with adjuvant chemotherapy.
Method.Registry data were used to recruit a sample of breast cancer patients (N = 61; mean age = 51.6 years) with no current evidence of disease who had completed adjuvant chemotherapy between 3 and 36 months earlier (average = 15.87 months). In addition, a peer nomination procedure was used to recruit an age-matched comparison group of women with no history of cancer (N = 59; mean age = 51.5 years). Both groups were mailed a survey to complete that included the Medical Outcomes Study Short Form 36 (SF-36) and the Center for Epidemiologic Studies Depression Scale (CES-D). These data were used to test the hypothesis that breast cancer patients previously treated with adjuvant chemotherapy experience impaired quality of life relative to their peers and to identify demographic and medical factors associated with individual differences in patient quality of life.
Results.Consistent with predictions, the postchemotherapy group scored poorer than the noncancer comparison group on the CES-D and on six of the eight subscales as well as the physical component summary scale of the SF-36 (p < 0.05). With regard to individual differences in patient quality of life, younger age and unmarried status were positively related to poorer mental well-being and greater depressive symptomatology (p < 0.05). Time since cancer diagnosis and chemotherapy completion were also positively related to greater depressive symptomatology (p < 0.05). In contrast, none of the demographic or medical variables assessed were related to physical well-being (p > 0.05).
Conclusions.Breast cancer patients appear to experience problems in multiple quality of life domains following the completion of adjuvant chemotherapy treatment. Demographic and medical characteristics explain individual differences in mental but not physical aspects of patient quality of life. These findings demonstrate the need for interventions to improve the quality of life in breast cancer patients previously treated with adjuvant chemotherapy.
Unable to display preview. Download preview PDF.
- 1.American Cancer Society: Cancer Facts and Figures. American Cancer Society, Atlanta, GA, 1999Google Scholar
- 2.Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339: 1–15, 1992Google Scholar
- 4.Greene D, Nail LM, Fieler VK, Dudgeon D, Jones LS: A comparison of patient-reported side effects among three chemotherapy regimens for breast cancer. Cancer Prac 22: 57–62, 1994Google Scholar
- 6.Maguire GP, Tait A, Brooke M, Thomas C, Howat JM, Sellwood RA, Bush H: Psychiatric morbidity and physical toxicity associated with adjuvant chemotherapy after mastectomy. Br Med J 281: 1179–1180, 1988Google Scholar
- 7.Ferrell BR, Grant M, Funk B, Garcia N, Otis-Green S, Schaffner MLJ: Quality of life in breast cancer. Cancer Prac 4: 331–340, 1996Google Scholar
- 21.Ware JE: SF-36 Health Survey: Manual and Interpretation Guide. The Health Institute, New England Medical Center, Boston, MA, 1993Google Scholar
- 22.Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measure 1: 385–401, 1977Google Scholar
- 24.Ware JE: SF-36 Physical and Mental Health Summary Scales: A User's Manual. The Health Institute, New England Medical Center, Boston, MA, 1994Google Scholar
- 25.Beeber LS, Shea J, McCorckle R: The Center for Epidemiologic Studies Depression Scale as a measure of depressive symptoms in newly diagnosed patients. J Psychosoc Oncol 16: 1–20, 1998Google Scholar
- 27.Hann DM, Jacobsen P, Martin S, Azzarello L, Greenberg H: Fatigue and quality of life following radiotherapy for breast cancer: A comparative study. J Clin Psychol Med Settings 5: 19–33, 1998Google Scholar
- 33.Manne SL, Sabbioni M, Bovbjerg DH, Jacobsen PB, Taylor KL, Redd WH: Coping with chemotherapy for breast cancer. J Beh Med 17: 41–55, 1994Google Scholar